FDA releases final regenerative medicine guidances

FDA Friday released final versions of two guidance documents that are intended to facilitate the development of regenerative medicines.

Draft versions of the Evaluation of Devices Used with

Read the full 282 word article

How to gain access

Continue reading with a
two-week free trial.